STAA Stock - Staar Surgical Co

STAA Stock Chart

STAA Profile

STAAR Surgical Company, along with its subsidiaries, specializes in the design, development, manufacturing, marketing, and sale of implantable lenses for ocular use and companion delivery systems. The company's flagship product line, the Visian implantable Collamer lens (ICLs), addresses a range of visual disorders including myopia, hyperopia, astigmatism, and presbyopia. Additionally, STAAR offers the Hyperopic ICL specifically designed to correct far-sightedness. Complementing its portfolio, the company provides preloaded silicone cataract intraocular lenses and injector systems essential for cataract surgery.

Beyond product offerings, STAAR Surgical Company supplies injector parts and other related instruments and devices essential for surgical procedures. Its clientele primarily includes healthcare providers such as ophthalmic surgeons, vision centers, surgical facilities, hospitals, government healthcare facilities, and distributors worldwide. The company's products are widely utilized by ophthalmologists globally, underscoring its pivotal role in advancing ocular healthcare.

Established in 1982 and headquartered in Lake Forest, California, STAAR Surgical operates a global distribution network spanning key markets including the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. The company markets its products directly through its own sales representatives and also collaborates with independent distributors across China, Korea, India, France, Benelux, Italy, and other international regions.

With a steadfast commitment to innovation and precision in ocular technology, STAAR Surgical continues to enhance its product offerings and expand its market presence worldwide. The company's strategic initiatives focus on advancing surgical techniques and improving patient outcomes through state-of-the-art implantable lens technologies, reinforcing its leadership in the global ophthalmic medical devices industry.

STAA Revenue Chart

STAA Earnings

Analyst Ratings